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ABSTRACT
Extracellular vesicles (EVs) have numerous potential applications in the field of healthcare and
diagnostics, and research into their biological functions is rapidly increasing. Mainly because of
their small size and heterogeneity, there are significant challenges associated with their analysis
and despite overt evidence of the potential of EVs in clinical diagnostic practice, guidelines for
analytical procedures have not yet been properly established. Here, we present an overview of
the main methods for studying the properties of EVs based on the principles of fluorescence.
Setting aside the isolation, purification and physicochemical characterization strategies which
answer questions about the size, surface charge and stability of EVs (reviewed elsewhere), we
focus on available optical tools that enable the direct analysis of phenotype and mechanisms of
interaction with tissues. In brief, the topics on which we elaborate range from the most popular
approaches such as nanoparticle tracking analysis and flow cytometry, to less commonly used
techniques such as fluorescence depolarization and microarrays as well as emerging areas such as
fast fluorescence lifetime imaging microscopy (FLIM). We highlight that understanding the
strengths and limitations of each method is essential for choosing the most appropriate combi-
nation of analytical tools. Finally, future directions of this rapidly developing area of medical
diagnostics are discussed.
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Introduction
Extracellular vesicles
The first observation of mammalian vesicle-like structures
was in 1967 by P. Wolf in platelet-free plasma after ultra-
centrifugation [1]. After years of extensive research, it is
nowwell established that vesicles are released by cells to the
extracellular milieu, serving various purposes such as cell-
to-cell communication, exchange of genetic information
and protection – the elimination of dangerous substances
and unwanted metabolites such as chemotherapeutics or
oxidized lipids from cells [2].
Mammalian EVs are secreted membrane-delimited
structures that contain material from the cytosol, subcel-
lular organelles and/or nuclear components, encapsu-
lated in a lipid bilayer. Although it is unknown whether
all cell types can secrete EVs [3], diverse cell lineages have
proven capacity to do so. The process of vesicle secretion
seems to be conserved throughout the evolution timeline
[4], providing evidence that EVs have a specific role in the
function of cells and organisms. The size (diameter) of
EVs is not uniform, as they can range from around 30 nm
up to a few micrometres. They have been detected in
most body fluids such as blood, urine, amniotic fluid,
cerebrospinal fluid, saliva, breastmilk and even nasal
secretions. It is now believed that EVs provide important
intercellular communication signals both in physiological
and pathological situations such as cancer and neurode-
generative diseases [5].
From the biochemical perspective, EVs and their
cargoes comprise several components, ranging from
membrane lipids and cytosolic proteins to nucleic
acids. More specifically, several techniques including
Western blotting and immune electron microscopy
have revealed the presence of proteins on the surface
as well as the interior of EVs, some of which are
ubiquitous (e.g. actin, kinases, heat-shock proteins)
while others vary significantly depending on the cell
type from which they originate, mainly lineage deli-
neating proteins and disease-specific markers. A few
examples of tissue-specific proteins are, among others:
major histocompatibility complex MHC class II and
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CD86 for EVs derived from antigen-presenting cells in
vitro [6], carcinoembryonic antigen (CEA) for EVs
derived from colon carcinoma cell culture [7], human
epidermal growth factor receptor 2 (HER2) from breast
carcinoma cell lines [8] and prostate cancer antigen-3
(PCA-3) as well as TMPRSS2:ERG from EVs isolated
from prostate cancer patients’ urinary samples [9].
Another basic structural component in all vesicles is
the lipids, with some of the most common being phos-
phatidylcholine (PC), sphingomyelin, cholesterol and
saturated fatty acids. Interestingly, nucleic acids have
also been found in extracellular vesicles; most com-
monly small RNA molecules such as mRNA, different
sizes of miRNA and low levels of ribosomal RNA.
DNA has also been found, not only in larger vesicles
which derive from apoptotic cells (apoptotic bodies)
but in smaller EVs as well [10,11]. Thus, genetic mate-
rial exchange implies a major role in cell-to-cell com-
munication and disease regulation. This basic
biochemical composition can vary significantly under
particular micro-environmental conditions such as
tumours and inflammation [4].
Because of their cargoes, EVs can be considered as
vehicles for disease biomarkers which have advantages
over routine blood biomarkers in common use [12].
Additional clinical applications of EVs are also cur-
rently under investigation. For example, EVs have
shown intrinsic therapeutic activity when isolated
from one specific tissue and administered to another,
as, for example, shown in the case of mesenchymal
stem cell-derived EVs which can have cardio-
protective properties [13]. Furthermore, vesicles iso-
lated from lymphoma models had pro-inflammatory
properties, triggering systemic immune responses,
indicating a potential use as vaccines [14]. Therefore,
effective analysis of EV phenotypes is essential for
understanding the properties of EVs and for shaping
their potential clinical use.
Challenges in EV analysis
Some of the most common difficulties in analysing
EVs are:
i. small size and biochemical complexity;
ii. pre-analytical methodologies for isolation and
purification, as the accuracy of the measurements
often depends on the purity of the sample,
especially for techniques with high sensitivity;
Typical isolation methods include gel permeation chro-
matography, ultracentrifugation, immunoaffinity cap-
ture or polymer-facilitated precipitation, among others
[12]. A variety of properties are used for EV isolation,
such as size, density, surface charge, hydrophilic inter-
actions with solvents and affinity for biological targets
[15]. In a recent approach, both capture and analysis of
EVs on the same device are based on microfluidics and
arrays (see later). Each technique has limitations and
combinations of methods are therefore often used.
However, in complex biological samples such as
blood plasma, achieving highly pure EV preparations
is especially challenging because of contamination of
the EVs with particulates such as large protein aggre-
gates (mostly lipoproteins) and chylomicrons, micelles
of lipids and proteins that cannot be reliably removed
by common purification methods such as centrifuga-
tion or size exclusion chromatography [16,17].
Moreover, the protocols for isolation and enrichment
of EV samples have not been standardized as yet, pos-
ing limitation on the wide use of EVs in clinical set-
tings [18].
More challenges in studying EV include:
iii. heterogeneity of EV populations;
iv. sub-populations of different phenotypes;
v. unknown concentrations;
vi. correlating specific EVs with specific origins;
A number of the above hurdles can be addressed by
optical methods, on which this review focuses. Optical
methods use light in order to read the information
encoded in the sample. The fundamental advantage of
optics-based techniques over calorimetric or chemical
readout methods is that, because light appears in
a spectrum of wavelengths, multiplexed analysis is per-
mitted, which is essential for clinical samples where
assessment of multiple molecules may be required.
Moreover, with the selection of the appropriate fluor-
ophore and target molecule, the different populations
and origins of EVs can be studied, while it is also
possible to precisely detect and localize biomolecules
using super-resolution microscopy, excluding particles
which cause impurities. Additionally, we acknowledge
that non-optical technologies (of which there are
many) can answer critical questions and common
approaches incorporate both; non-conventional tools
and future approaches will also be discussed briefly
later (see Emerging fluorescence methods).
Why optical methods?
The aim of this review is to summarize the optical tools
researchers have used in analysing the phenotype and
functions of EVs, emphasizing the seemingly endless
potential of fluorescence-based approaches. In general,
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optical methods provide unique opportunities for real-
time, multiplexed and rapid analysis in complex envir-
onments. As the methods for EV isolation and size
measurement appear well accepted among the research
community (and have been well reviewed elsewhere),
we herein focus on the biological properties of EVs and
the specific analytical techniques which can be applied
on the nanoscale. In parallel, with the rapid develop-
ment of labelling technologies and fluorescent dye
chemistry, fluorescence is nowadays a versatile tool
that offers multiple options for a variety of analytical
and imaging modalities. As there is not a standardized
workflow for phenotypic studies of EVs, we present an
overview of the classic as well as the latest approaches
used in the field [19]. In brief, we review analytical
strategies involving: nanoparticle tracking analysis,
flow cytometry, fluorescence microscopy and super--
resolution microscopy, quantitative polymerase chain
reaction (PCR), fluorescence lifetime and anisotropy
measurements and novel advances in the field of
microfluidics and microarrays (Figure 1), and we pro-
vide an overview of the labelling technologies used
on EVs.
From the techniques listed, fluorescence measure-
ments can be generally divided into two subgroups: A)
steady-state and B) time-resolved analysis. A) Steady-
state fluorescence spectra result from the excitation of
the sample with a continuous light beam and the
recording of the emission intensity. In practice, steady-
state measurements average the recorded parameters
from the initiation until the completion of the phe-
nomenon. B) In time-resolved techniques, data are
collected in a time-dependent manner, resulting in
a fluorescence decay curve representative of not only
the steady-state aspects but also transient information
on the phenomenon under study (including quench-
ing, molecular rotation and energy transfer) [20]. Most
methods fall in the steady-state category, apart from
FLIM and fluorescence anisotropy, in which the life-
time of the fluorophores is used.
Fluorescence provides information about a range of
processes, such as the interaction of fluorophores with
the solvent or rotational freedom and molecular dis-
tances [21]. Here we discuss in detail the potential of
fluorescence in the detection and nanometrology of
EVs. However, there are also limitations in the use of
Figure 1. Simplified schematic overview of the main optical techniques used for EV analysis. Centre image: EVs secreted from cells.
Techniques where EVs are analysed in suspension include A: nanoparticle tracking analysis, B: flow cytometry, C: fluorescence spectroscopy
(lifetime, polarization). Methods where EVs are immobilized on a surface include D: fluorescencemicroscopy for isolated EVs (for live imaging,
EVs can be in suspension) and E: microarrays and microfluidics. Also, F: quantitative PCR, in which the EVs are lysed.
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fluorescence-based techniques for the analysis of bio-
logical material that are mainly attributed to interfer-
ence from an intrinsic fluorescence background signal,
the need for labelling, as well as photobleaching and
quenching by oxygen. Interestingly, many of these
drawbacks are ameliorated by the development of
stable fluorophores such as quantum dots (QDs) to
minimize photobleaching, as well as the use of far-red
dyes to improve tissue penetration and eliminate auto-
fluorescence interference. Indeed, in the case of
Stimulated Emission Depletion microscopy (STED)
microscopy, photobleaching has been put to good
effect in providing the very principle upon which the
technique is founded [20,22].
A simple categorization of the physical state of the
sample and the associated optical analytical approaches
is as follows:
● Analysis of intact EVs, in which the sample can
be:
○ in the form of a dynamic suspension (nanopar-
ticle tracking analysis (NTA), flow cytometry,
fluorescence anisotropy, live microscopy);
○ captured on a surface (immunomagnetic beads,
arrays, microfluidics, microscopy on fixed
samples);
● Lysed EVs for molecular analysis (PCR microflui-
dic systems).
Most techniques analyse either sizing (e.g. Dynamic
Light scattering, DLS) or molecular functionality (e.g.
flow cytometry, PCR) and there is a need for advanced
techniques in the areas of fluorescence NTA, micro-
scopy and microfluidics that offer both size and func-
tional information simultaneously (Figure 1). The
potential for EV analysis is not limited by the current
techniques, as there are many possible routes for use of
complex methods, combining the above, which can be
used to answer numerous critical questions about EVs
that have not yet been addressed.
EV labelling technologies
In order to utilize imaging and spectroscopic techni-
ques based on fluorescence, either direct or indirect
labels need to be introduced to the EV target sample.
Examples include the following options for labelling
strategies: (i) staining via the sequestering of free dyes
directly into the lipid bilayer via hydrophobic interac-
tions or by genetically encoding fluorescent proteins,
(ii) selection of fluorophore for the formation of
a covalent chemical bond with a probe which has
affinity for a vesicular compartment, and (iii) the selec-
tion of a suitable affinity probe such as immunoglobu-
lins, nanobodies or aptamers. The target components
can be nucleic acids (RNA; and also DNA, including
via apoptotic bodies [10]), membrane lipids and pro-
teins, and intravesicular molecules, some of which are
ubiquitous and others showing high specificity for par-
ticular EV sub-types. The selection of an appropriate
fluorescent reporter depends on factors including selec-
tivity for a tissue compartment, excitation and emis-
sion spectra and other physical and biological
properties such as stability, photobleaching, possible
toxicity to the specimen, intensity of the signal and
whether surface-based measurements or EV samples
in suspension are being analysed. A brief overview of
the various fluorescent probes already described in the
literature is shown in Figure 2.
A broad categorization of the main groups of label-
ling options mentioned earlier is given here in more
detail:
(i) staining via hydrophobic interactions and
genetically encoded fluorescent proteins
Free fluorescent dyes are commonly used to stain the
total EV population non-specifically, either by lipophilic
interactions with the membrane or by diffusion and
retention inside the vesicles. Some dyes associating
with the membrane of human or bacterial EVs used
for flow cytometry measurements and fluorescence con-
focal microscopy for cellular uptake tracking and traf-
ficking include, among others, BODIPY-PC (conjugated
with phosphatidylcholine), DiD, Dil, DilC, Octadecyl
rhodamine B chloride (R18) [23] dyes from the
BODIPY range as well as PKH67 and PKH26 [24–26].
Fluorescent proteins such as enhanced green fluorescent
protein (EGFP) can also become endogenous probes for
various cell compartments upon appropriate genetic
manipulation of cells and importantly, the majority of
these proteins and dyes are compatible with live tissue
imaging [27]. Some dyes, non-commercialized to date,
are wash-free nucleic acid indicators, examples being the
membrane permeable dyes acridine orange and thiofla-
vin T [28]. Another recently described dye emitting in
the near infrared (IR) can stain EVs in suspension or
gives the option to generate fluorescent vesicles from
pre-stained cells [29]. An example of a dye that can
sense the membrane integrity of EVs is Calcein AM,
which becomes fluorescent only after hydrolysis by
esterases confined to the inside of non-permeabilised
vesicles [26].
For membrane and lipid rafts studies, there is a large
variety of fluorophores which intercalate into the lipid
bilayer. These are currently used widely on cells and have
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potential application to vesicles. The most common cate-
gory is the BODIPY range of dyes which can bind to
different parts of the acyl chain of membrane lipids, thus
providing images from different depths of the lipid
bilayer [30,31]. Environmentally sensitive dyes such as
Laurdan (6-lauryl-2-dimethylamino-naphthalene), car-
bocyanine, DPH and di-4-ANEPPDHQ appear to alter
their fluorescence properties according to the polarity of
the microenvironment, which corresponds to the relative
rigidity of the membrane, or abundance of the lipids in
the local domain, thusmaking it possible tomap different
membrane regions [32–34].
(ii) fluorophores used for labelling an affinity probe
Red/near-infrared (NIR) fluorescent dyes offer
a number of advantages for EV analysis. In particular,
their longer-wavelength excitation usually minimizes
both the background endogenous fluorescence from the
sample under study and the detection of Rayleigh scattered
excitation [35]. Some advantages of red dyes have been
brought to bear in medical diagnostics and imaging using
indocyanine green (ICG), which fluoresces up to ~900 nm.
ICG is approved for intravenous use and widely used to
detect cardiac, circulatory, hepatic and ophthalmic condi-
tions [36,37]. Red/NIR aromatic dyes are often based on
cyanine, xanthene, oxazine or coumarin groups. Their
common limitations are their susceptibility to photo-
bleaching and short fluorescence decay times of ~1 ns,
the latter limiting application to binding studies based on
fluorescence polarization anisotropy. Recently, a range of
more photo-stable red/NIR azadioxatriangulenium
(ADOTA) dyes with a fluorescence lifetime of ~20 ns has
been reported. The NHS ester of ADOTA has been used
with fluorescence anisotropy to study anti-rabbit
Immunoglobulin G binding to rabbit Immunoglobulin G;
a 150 to 300 kDa increase resulting in a rotational correla-
tion time increase of ~50 to 90 ns [38]. In addition,
methyl-ADOTA has been shown to improve precision as
compared to ultraviolet dyes by not exciting auto-
fluorescence in silica colloids with uniform nanoparticle
radii in a range – 3.5 nm to 11 nm –with respect to EVs of
Figure 2. Schematic representation of the relative sizes of EVs and types of fluorescent labels and molecular probes.
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similar size, the latter corresponding to a rotation correla-
tion time of ~1400 ns [39].
Dyes intended for super-resolution microscopy
based on stochastic activation of fluorophores such as
Stochastic Optical Reconstruction Microscopy
(STORM) are special organic molecules or proteins
which have blinking properties (reversible photoswitch-
ing) such as the AlexaFluor and the ATTO range of
molecules [40]. Techniques involving photoactivation
such as PALM usually require fluorescent proteins (e.g.
Photoactivatable-GFP) in cases where exogenous cellu-
lar expression of the fluorescent protein is possible [41].
More details on the applications of high-resolution
microscopy on EVs will be described later.
Luminescent nanoparticles such as inorganic QDs
absorb light across a specific wavelength region and
emit narrower spectral bands of light depending on
the composition, size and surface properties of the
nanocrystal. Their spectral versatility and capacity for
surface modification have made them popular for bio-
medical applications [42]. Apart from their use as
a direct fluorescent agent conjugated with probes of
biological relevance, they have also been used as parts
of FRET pairs for the detection of nucleic acid
sequences as, for instance, they have been coupled
with thiazole orange to detect double-stranded oligo-
nucleotides [43]. Pairing quantum dots with an apta-
mer against the EpCAM molecule and quenchers has
been shown to generate a “beacon” that lights up in the
presence of the target, thus providing a detection probe
for the circulating metastasis indicator, EpCAM [43].
QDs are suitable for NTA studies of EVs, as they show
stability in the emitted intensity over long periods of
excitation (see also NTA section below). Other bright
nanoparticles include nanodiamonds, upconversion
nanoparticles and gold nanoparticles, which show opti-
cal properties and small size, suitable for EV labelling
and single-molecule analysis, such as advanced micro-
scopy and spectroscopy [44].
(iii) options for affinity-binding reagents
Although antibodies and Fab domains are being used
for specific EV labelling, extrapolating their potential
from their well-tried use on cells, the size of EVs sug-
gests that smaller labelling probes can be more effective,
as they can potentially increase the label-to-EV ratio.
Nanobodies are fragments engineered from antibodies
found naturally in camelids (camels, llamas) and carti-
laginous fish (sharks). They are single-domain compo-
nents of the variable parts of an antibody, with a weight
of 15–25 kDa, significantly smaller than Fab fragments
(around 50 kDa) and whole immunoglobulins (around
150 kDa) [45]. Besides their therapeutic applications,
nanobodies are also being used to image biological
systems [46]. Fusion with fluorescent proteins is
a common method to create fluorescent probes (chro-
mobodies) for fixed and live cell imaging with conven-
tional microscopy [47], as well as super-resolution
techniques [48]. Conjugation with chemically synthe-
sized chromophores for intraoperative imaging [49] or
even with QDs illustrates their applications [50]. With
EVs, there are examples of nanobodies designed against
CD9, an EV surface marker [51], as well as lipid-
nanobody conjugates embedded in the membrane
enabling EV targeting [52–54], thus creating possible
applications for the immobilization of EVs on arrays,
beads or microfluidic systems besides direct fluorescent
labelling.
Nucleic acid aptamers are synthetic single-stranded
DNA or RNA sequences that are selected based on
their high specificity for a target species and can be
custom-engineered with different labels to amplify the
optical signal associated with EV interaction. DNA
dendrimers are a type of 3-D macromolecular struc-
tures with numerous binding sites, incorporating DNA
sequences and have been used as part of an EV capture
and detection platform, where the capture of EVs on
CD63 magnetic beads triggers the release of a DNA
probe which hybridizes on other hairpin structures and
initiates a cascade of signal which is finally amplified by
the dendrimers [55]. CD63 aptamers have been also
conjugated with QDs for the labelling of EVs for super-
resolution microscopy [56] and as part of a cancer-
derived EV detection system using clinical serum sam-
ples [57]. A method for quantifying EVs and selectively
labelling specific sub-classes using aptamers has been
recently developed with the following principle: the EV
population was labelled with a construct coupled to
a DNA oligonucleotide sequence and the signal ampli-
fied by an isothermal nucleic acid detection assay based
on the amplification of DNA fragments and enzymatic
generation of fluorescent fragments [58].
Analytical techniques
Nanoparticle tracking analysis
Nanoparticle tracking analysis (NTA) is a relatively
recently developed (2006) technique, now distributed
by Malvern Panalytical Ltd (UK), which can be gener-
ally applied to many types of nanoparticles ranging
from 30 nm to 1 μm, thus encompassing many EVs
[59,60]. In more detail, the sample is a dilute liquid
suspension of particles illuminated by a laser beam
(Figure 1A). The scattered light from the particles is
collected via a microscope objective lens and recorded
at video frame-rates, the choice of camera sensitivity
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depending on whether Rayleigh scattering only or also
fluorescence-based tracking is recorded. The software
can identify a particle and track its trajectory from one
frame to the next, as well as measure its velocity. The
value recorded for velocity is applied on the two-
dimensional Stokes–Einstein equation to obtain the
particle hydrodynamic diameter [61]. NTA measure-
ment is relatively fast (requires a few minutes) with
hundreds of individual tracks collated to provide
insight into the colloidal composition and provides
real-time imaging of particles while the phenotype of
the particles can also be determined [60].
This technique is one of the most widely accepted
methods for EV size and concentration measurements,
and can also be used for EV phenotyping using fluor-
escent markers. Because of the prolonged exposure of
the sample in the laser beam, the most popular fluor-
escent labelling is via QDs, as they are generally photo-
stable compared to other commercial fluorophores and
this strategy is overall considered more sensitive than
flow cytometry for particles in the sub-micron size
range [62]. A number of research groups have reported
the use of NTA for EV phenotyping. Some of the
markers studied by the attachment of the relevant anti-
body to quantum dots are the surface urinary marker
CD24 for urine-derived exosomes [63] and CD63 along
with EpCAM for EVs isolated from ovarian cancer
patients’ blood [64]. EVs from maternal blood were
screened for CD63 and placental alkaline phosphatase
(PLAP), an indicator of placental exosomes, in order to
detect obesity-related gestation complications [65] and
in another study, in order to monitor foetal growth
restriction [59]. Placental EVs directly isolated from
the perfusate of ex vivo tissue were also similarly ana-
lysed for the placental marker NDOG2 [62]. An
approach different from the QDs system was applied
on Jurkat cell-derived EVs which were phenotyped for
CD45 by immunocapture with anti-CD45 coated mag-
netic beads and subsequent measurement of the EV
depletion level from the initial population [66].
Regarding the relative advantages of NTA over other
techniques discussed later, NTA measurements are rela-
tively fast (require a fewminutes), with non-sophisticated
sample preparation procedure and provide real-time ima-
ging of unlabelled or labelled particles. It is also particu-
larly sensitive for samples containing small populations of
larger particles because the intensity of the scattered light
is proportional to the sixth power of the diameter. At the
same time, this means that size determination could be
less accurate, especially in populations of smaller parti-
cles, where dust particles or protein aggregates can inter-
fere in the measurement. This poses an additional point
of limitation, related to the sample purity. The presence of
large particles reduces the number of the small particles
the software can detect [60]. Different size populations
can bemeasured only when there is a 1.5fold difference in
their diameter, and because the precision depends on the
refractive index of the specimen, it is suggested that
samples with high size heterogeneity should be measured
more than once [67]. Currently, instruments with two
different fluorescence channels are under development,
as discussed in the “Future outlooks in EV analysis”
section [68].
Flow cytometry
A versatile technique to characterize labelled or unla-
belled cells and particles derived from biologic samples
is flow cytometry. The working principle of this tech-
nique is the sensing of cells or particles in suspension,
streamed through a laser excitation path [69]. Once the
cells or particles pass through the excitation source
(usually laser beam), the light is scattered in all direc-
tions and the information obtained from the orienta-
tions of the detected photons can be translated into size
(forward scatter) and granularity of the sample (side
scatter). The electronic system converts the light signal
to a digital readout and a computer gives the operator
the options of various plots and histograms to interpret
the data which apart from size and granularity, give
information on the presence of a fluorescent label on
each detected event [70].
Flow cytometry was originally designed for larger
particles (typically >200–500 nm), substantially larger
than the smaller end of the EV size spectrum, but has
been used to count, sort and investigate the phenotype
of EVs, although their small size raises a matter of
controversy for this technique [71,72]. As it is generally
accepted that conventional instruments are optimized
for larger particles, there are examples of custom-built
flow cytometers or specifically adjusted instrument
parameters which are dedicated for EV samples [73–
75], giving special emphasis to judicious fluorescent
labelling to avoid artefacts resulting from dye aggrega-
tion. Some modern instruments can resolve fluorescent
particles in the range of 100 nm [76] and it has been
shown that imaging and high-resolution flow cytome-
try offers a new approach in EV analysis [77,78 and 79
respectively].
Another commonly used approach for flow cytome-
try of EVs is immunocapture on magnetic or non-
magnetic beads to form a larger complex which can
be detected within the conventional size detection lim-
its of cytometers [80,81]. Some of the most popular EV
specific targets are the CD9, CD63 and CD81 mole-
cules on the delimiting EV membrane surface [3]. The
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immunocomplex can also apply to other techniques
within the context of biochemical analysis and micro-
scopy. This can be the basis for further phenotyping
studies with the use of special fluorescence-labelled
antibodies, but it does not provide direct information
on EV size [82–84].
Flow cytometry is a popular method for clinical
analyses as it offers the advantages of a rapid and
versatile tool for which fluorescent probes are well
established and optimized. However, there are con-
cerns regarding the sensitivity of the system as applied
to EVs. Alternative techniques such as NTA which are
designed for sub-micron particles and offer more sen-
sitive phenotype analysis [62] demonstrate that sectors
of the EV population are not detectable by flow cyto-
metry [85], mainly because of the low signal/noise ratio
of detection in Rayleigh scattering as smaller particles
move through the detection channel. It is also acknowl-
edged that while the more advanced imaging flow
cytometers offer a resolution limit of ~100 nm, there
are other complementary techniques which cover the
vesicle sizes below 100 nm, such as fluorescence
Nanoparticle Tracking Analysis, electron microscopy
or protein and lipid profiling [67].
Fluorescence microscopy
With EV diameters ranging from a few nanometres up to
a few hundreds of nanometres, the diffraction-limited
resolution capabilities of a microscope (usually 200–300
nm) in the study of such small particles are unworkable.
However, although the small size of many EVs does not
allow their visualization in an unlabelled state by bright-
field illumination, the attachment of a fluorophore which
emits light enables the imaging of EVs and their interac-
tions with live cells. Imaging by microscopy is particu-
larly useful for the study of the localization of the
particles in cells or tissues, or presence of
a fluorescently labelled target. The majority of the cases
discussed in this section refer to confocal microscopy, in
which only a small defined area of the sample is exposed
at each time excluding all the out-of-focus light, in con-
trast to wide-field imaging where the total area of the
specimen is illuminated and the precision of the fluor-
ophore localization is lower [86].
Several applications of confocal imaging of EV
include the observation of vesicles inside the Golgi
apparatus with a size of approximately 50–80 nm
[87], and in addition, immobilization of EVs on
a solid surface is used to directly visualize the indivi-
dual vesicles [88], and also their localization in cells
after uptake [89]. Cancer cells co-cultured with EVs
have been imaged with fluorescence microscopy [90],
giving possible implications on uptake mechanisms.
An example of live tracking of EVs in a living organ-
ism comes from Verweij et al. by using zebrafish in
which all CD63-positive EVs were fluorescently
labelled. This model expressed CD63-pHluorin
(emits green fluorescence) and therefore, endogenous
EVs were labelled and could be tracked in real time
in vivo by confocal microscopy [91]. What is more,
EVs have been visualized in live tissue by fluorescence
optical imaging and multiphoton microscopy in intra-
vital window methods (see Table 1 for a summary of
references on live microscopy of EVs).
Among the advantages of fluorescence microscopy are
the direct localization of the labelled target within the
system of interest (cell, tissue or organism), the ability to
track the EVs in real time and the fact that image analysis
software can nowadays give accurate quantitative results
on colocalization of fluorophores, tracking speed and
directionality, etc. In addition, in contrast to other
microscopy methods such as STORM, PALM and
FRET, there is a wide variety of fluorophores which can
be used for confocal imaging. The main limitations of
this imaging strategy mainly pertain to the resolution
limit, allowing only larger EV to be accurately imaged,
and the sample preparation procedure, which can some-
times involve long protocols including fixation. Another
issue always appearing in microscopy is the selection of
the appropriate target for labelling, and the suitable
fluorophore which needs to be stable and resistant to
photobleaching from prolonged exposure [86].
Super-resolution microscopy
An excellent example of the most advanced applica-
tions of fluorescence is super-resolution microscopy,
where different techniques use distinct properties of
fluorescence to break through the light diffraction
limit (250 nm axial and 450–700 nm lateral resolution).
Among the most popular techniques are Structured
Illumination Microscopy (SIM) which is based on the
illumination of the specimen by a striped pattern [99]
and Stimulated Emission Depletion microscopy
(STED), using a second laser to temporarily bleach
the fluorophore around the focal point, thus achieving
sharp emission from only a small point of the speci-
men, as described by S. Hell [22]. Controlled or sto-
chastic activation of the fluorophore, “blinking”,
introduces another range of methods which push the
resolution limit even lower, achieving single-molecule
localization (SMLM) [100]. The most common of these
are Photoactivation Localization Microscopy (PALM)
which employs genetically expressed photoactivatable
fluorescent proteins [41] and direct Stochastic Optical
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Reconstruction Microscopy (dSTORM) where the
underlying chemistry causes the fluorophore to blink
in a non-controlled pattern reducing the density of the
emitting molecules at each time-point. Recording
a series of frames in each of which only a few molecules
emit, it is possible to precisely localize the fluorescent
molecules and by adding all frames together, the total
image is reconstructed in super-resolution down to ~20
nm [40,101]. Total Internal Reflection microscopy
(TIRF) is a sample illumination method that uses an
evanescent wave of light to image the planar surface of
the specimen in the areas of contact with the coverslip
and is often used in combination with SMLM
approaches [102].
EVs have been imaged with PALM and dSTORM to
study the interactions of exosomes with neurons in
Alzheimer’s disease. CD9-labelled vesicles were found in
the cytoplasm and endosomes of dendrites isolated from
mouse brain tissue with a precision of 25 nm [103]. In
another study, CD63 aptamers were conjugated withQDs
to label the EV surface and the EV-QD complex was
imaged using the principles of SMLM, showing the
potential of QDs as blinking fluorophores [56]. The
same group also used TIRF and SMLM to image EV
miRNA and membrane receptor both in vesicle prepara-
tions and in living cells [104], while miRNA imaging has
been reported from Oleksiuk et al., as well [105].
Labelling CD63-targeting antibody with Alexa Fluor 647
and anti-HER2 antibody with Alexa Fluor 488 enabled
imaging with TIRF and simultaneous dual colour PALM/
dSTORM for breast cancer cell line-derived EVs alone, as
well as upon interaction with non-cancer cells [106]. EVs
from mesenchymal stem cells were also labelled with
PKH26 and with exosome-specific markers and their
intracellular localization in bone marrow mesenchymal
stem cells was characterized by SIM [26]. STED is also the
method chosen in neuroscience for synaptic vesicle ima-
ging, where a synaptic vesicle membrane-specific mem-
brane protein, synaptotagmin was targeted with Atto532-
coupled antibodies [107]. A more recent and currently
under development method using super-resolution
microscopy is intracellular tracking of EV after uptake,
as well as sizing (with an approach alternative to NTA,
taking advantage of single-molecule fluorescence) [108].
The benefits of super-resolution microscopy and
SMLM are by definition the ability to break the resolu-
tion limit and image particles non-detectable by
conventional microscopy. It is therefore an approach
very suitable for EV analysis regarding size, concentra-
tion and content, although this does not come without
limitations, mainly from the perspective of sample pre-
paration and the variety of imaging modes which are
possible. In more depth, although the protocols forTa
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fixation and staining of the biological materials are
considered well established for confocal microscopy,
when it comes to SMLM, the precision of imaging
reveals insufficient labelling of all target molecules
which can be due to inadequate staining with affinity
reagents or inappropriate labelling strategy. In other
words, for imaging intended for quantitative analysis,
the location of the target epitope on the particle under
examination is a point which needs to be carefully
considered when choosing the appropriate affinity
probe and labelling conditions. Another limitation
which was only discovered with the advent of SMLM
approaches is the fixation method, as it has been shown
that the structure and clustering of the target can vary
significantly with different fixation protocols [109].
Moreover, a drawback inherent to STORM and
PALM because of the emission mechanism of the
fluorophores is that a large number of the convention-
ally used dyes are not applicable in these methods,
narrowing down the availability of fluorescent mole-
cules. Also, specifically referring to STORM, this tech-
nique is mostly recommended for fixed samples, as the
specimen needs to be embedded in a special buffer with
reducing agents – to induce the “blinking” effect of the
fluorophores – in which most live cells cannot be
maintained healthy for periods of time sufficient for
imaging. This poses limitations in EV tracking in live
cells and therefore, an alternative approach (such as
STED [110]) would be recommended in those cases
when the biological system is not compatible with the
imaging conditions [111].
Fluorescence lifetime imaging microscopy
Fluorescence lifetime imaging microscopy (FLIM) dif-
fers from steady-state fluorescence microscopy as in
the former, the contrast of the image is generated by
the difference in the excited state lifetime of the fluor-
ophores rather than the total fluorescence intensity in
case of the latter. In addition to fluorescence localiza-
tion and intensity information provided by steady-state
microscopy, FLIM is especially useful for studying the
spatial arrangement of biological membranes, as fluor-
escence lifetime of a dye depends on its microenviron-
ment [112,113].
Imaging membrane microdomains of EVs can be
useful in revealing potential mechanisms of interaction
with other membranes and especially cells, and has
been used by several groups for cellular uptake ima-
ging. EVs from osteosarcoma cells and their interac-
tions with lung tissue have been imaged with FLIM
using the dye PKH67, providing high-quality images of
the membrane [24]. A detailed study on the uptake
mechanisms for different subsets of EVs was presented
by Saari and colleagues, in which paclitaxel-loaded
exosomes and microvesicles interacting with PC-3
cells were imaged in real time. Paclitaxel was labelled
with Oregon Green and the vesicles were generally
stained with the membrane dye, DiD. FLIM revealed
the localization, concentration and lifetime of the fluor-
ophores within the cells and it was shown that exo-
somes have a different uptake mechanism from
microvesicles [114]. Another application of FLIM is
described by Grela et al. where the incorporation of
the anti-fungal drug amphotericin B in membranes was
investigated by treating cell lines with the drug and
imaging the secreted EVs, recording both the lifetime
and anisotropy. The images reveal the different micro-
domains on the EV membrane and show that ampho-
tericin replaces cholesterol in the membrane [115].
Overall, as FLIM is based on the lifetime of the
fluorophores, it is independent of probe concentration,
excitation intensity or photobleaching and can be used
even with spectrally similar fluorophores, given that
their decay times are different. Moreover, it can
directly detect differences in the probe’s microenviron-
ment, without the need for special treatment of the
specimen. On the other hand, the main drawbacks
are the need for expertise in lifetime spectroscopy in
order to understand the data and the special equipment
required [116]. Another limitation of FLIM is the slow
acquisition times, however, as seen in the “future out-
looks in EV analysis” section, there are currently hard-
ware developments which have started addressing the
issue, providing faster imaging [117].
FRET
Förster Resonance Energy Transfer (FRET) is the phe-
nomenon whereby energy from one fluorophore is
transferred non-radiatively to another via dipole–
dipole interaction when the two molecules show some
spectral overlap (resonance) and are practically less
than 10 nm apart in space. Thus, these measurements
are used to determine molecular distance and interac-
tions between fluorescently labelled targets.
The combination of FRET/FLIM has enabled quan-
tification of the FRET effect using the advantages of
time-resolved lifetime spectroscopy and has been useful
in the case of HER receptor in breast cancer since the
status of dimerization of HER provides more valuable
prognostic/diagnostic information than the levels of
expression. HER monomers on circulating EVs were
immunostained with the FRET pair AlexaFluor 546
and Cy5 and imaged with the above combination of
techniques to quantify the different forms of HER
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[118]. Besides phenotyping studies, FRET pairs of dyes
have served as proximity sensors for EV fusion with
liposomal membranes by the use of lipids labelled with
NBD and rhodamine and subsequent recording of the
fluorescence spectra [119]. A combination of fluores-
cein (FITC) and rhodamine-labelled peptides were
loaded on exosomes and FRET was used to measure
their proximity on the same vesicles in a study con-
ducted by Gao et al., showing potential for loading and
targeting vesicles from patients by the attachment of
a special peptide on the CD63 surface molecules [120].
An indirect application of FRET on vesicles was the
measurement of this effect on cells which contained
a fluorescent protein FRET pair for tau protein, upon
treatment with exosome-like vesicles. The results
showed that the vesicles had an impact on the aggrega-
tion of tau, which is implicated in Alzheimer’s disease
pathogenesis [121].
Although FRET offers unique imaging information
over other microscopy techniques, the principles of
Förster resonance bring disadvantages, as the appro-
priate combination of emitters needs to be carefully
selected. It is also observed that the signal-to-noise
ratio (SNR) can be low and emission is sensitive to
changes of the microenvironment of the fluorescent
molecule; however, recent advances in the field are
tackling these issues [122].
qPCR
Quantitative Polymerase Chain Reaction is a technique
based on the well-established PCR method, which is
enhanced with numeric quantitative data in contrast to
the traditional PCR which is semi-quantitative. This
method assesses EV populations in total, rather than single
EVs, as it requires vesicle lysis. The basis for its inclusion
here is the use of fluorescence to detect the amount of
nucleic acid produced in every cycle of the reaction. As
the majority of EV studies are conducted on mRNA and
miRNAs, qPCR is a common method of choice [123].
Microfluidics and microarrays
Microfluidics
Microfluidics-based technologies continue to evolve for
biological and analytical applications and there have
also been recent innovations in the field of EV detec-
tion. Most often, these involve the capture and separa-
tion of EVs on a solid substrate surface localized with
a microfluidic compartment. There are several strate-
gies for EV immobilization and these can be distin-
guished as passive (using physicochemical properties
and forces such as immunoaffinity, size exclusion and
flows) and active (electroactivity, magnetic and acous-
tic forces). The analytes can be detected by a variety of
different methods depending on the desired readout
signal. For instance, nucleic acids can be amplified on-
chip with PCR-based methods, proteins can be
detected with principles similar to enzyme-linked
immunosorbent assay (ELISA) assays, or the EVs can
be lysed, releasing their contents which can be subse-
quently processed off-chip for the detection of various
components such as Western blots or mass spectro-
metry [124,125].
EV secretion from single cells has been presented
on a microfluidic setup, where the EVs secreted by
each cell are captured on CD63 beads and visualized
by fluorescence imaging. Antibodies labelled with PE
were attached on the EVs captured on microbeads
and the values of fluorescence intensity of the beads
could indicate the rate of cell secretion, concentra-
tion and phenotype of the vesicles [126]. A biochip
which promises simultaneous EV extraction from
serum and detection of the pancreatic cancer bio-
marker glypican I mRNA has been reported by Hu
et al. using a catalysed hairpin DNA circuit (CHDC)
on special lipid-polymer nanoparticles. When EVs
are captured on the surface of the nanoparticles,
EV RNA interacts with the hairpin DNA complex
which emits an amplified signal upon hybridization,
enabling detection of low levels of mRNA expression
[127]. A platform with readout that can be measured
on conventional instruments such as a plate reader is
also possible with the appropriate spatial arrange-
ment of the CD63-coated surface. Labelled EVs are
infused on this surface and the retained EVs are
measured for fluorescence intensity, not only for
quantitative studies but also for biomarker analysis
[128]. A miniaturized alternative version of fluores-
cence flow cytometry was developed by Friedrich
et al. where individual EVs were transported in
a flow stream and visualized on a microscope. The
results on synthetic lipid particles showed potential
applications in measurement of concentration and
size distribution, as well as dual colour imaging for
different markers [129].
Other applications of microfluidic systems have
been developed for the capturing and concentration
of EVs from biopsies, where the amount of available
vesicles is limited (e.g. cerebrospinal fluid). Taking
advantage of the natural surface charge of EVs, an ion-
selective membrane can be used as a trap for vesicles
flowing onto this surface, resulting in maximized con-
centrations and a surface saturated with EVs for
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further studies [130]. EV enrichment for mRNA recov-
ery and subsequent analysis has been achieved specifi-
cally for tumour-derived EVs using a cocktail of
capture antibodies. The device was applied on blood-
derived EVs from glioblastoma patients and the RNA
analysis confirmed the detection of EGFRvIII muta-
tion, a glioblastoma biomarker [131,132]. The expres-
sion and phosphorylation of IGF-1R were measured
with immunodetection and chemifluorescence reagents
after vesicles from 30 μl of plasma from non-small-cell
lung cancer patients were applied on a microfluidic
system [133].
The miniaturization of EV capture and detection
processes on microfluidic chips has promoted research
towards the development of hand-held analysis
devices, such as the system reported by Ko et al.
[134]. The basis of this invention was the coupling of
an EV chip on a smartphone camera to detect fluores-
cence signal enzymatically amplified from an assay
similar to ELISA. Detection with a fluorescence ELISA-
like assay was the method chosen for plasma EV ana-
lysis from cancer patients, after deposition of 2 μl
plasma on a special graphene oxide-induced nanopor-
ous material [135]. The results proved that it was
possible to discriminate between cancer and healthy
patient samples, without the need for processing. In
addition, another system used an ELISA-based process
to couple EVs with magnetic beads and generate dro-
plets of individual beads, measuring their intensity by
fluorescence after enzymatic reaction. This platform
has a lower detection limit of 10 vesicles, providing
the potential for sensitive EV detection for disease
diagnosis [136].
Microarrays
The development of antibody arrays on solid surfaces
offers high-throughput screening for various EV mar-
kers often by detection of fluorescence signal.
A cocktail of antibodies against CD9, CD63 and
CD81 were used by Jørgensen et al. to capture the
total EV population from blood plasma on array
spots, followed by visualization using fluorescent detec-
tion antibodies. This has enabled screening for 21
different EV surface antigens with the use of less than
10 μl of sample [137]. Later on, the same group
reported the development of an array with capacity of
screening 60 surface antigens from blood plasma with-
out prior processing or enrichment [138]. Another
established array, initially developed for leukaemia
cells (DotScan), has been successfully implemented on
vesicles for phenotypic analysis by fluorescence and
chemiluminescence-based immunoassays [139].
Emerging fluorescence methods with potential
application on EVs
In this section, we discuss some non-conventional tools
with potential for EV analysis, such as fluorescence
anisotropy and other optical methods.
Fluorescence anisotropy takes advantage of the
polarization properties of fluorescence that can be
used to describe rotational diffusion and energy
migration. More specifically, when fluorescent mole-
cules are exposed to a polarized excitation source
(i.e. light waves vibrating only in a single plane,
with all other planes excluded), only the molecules
found in the same plane as the polarized light will
get excited. Due to Brownian motion and other
energy migration phenomena, the excited polarized
molecules will fluoresce while rotating back to ran-
domized planes (depolarization) [20]. The depolari-
zation decay curve of the fluorophore can provide
information about its rotational pattern, which is
highly dependent on the interactions with the local
microenvironment. This method is based on fluores-
cence lifetime instrumentation and the data can be
recorded either in steady-state or in a time-resolved
manner. The most common time-resolved measure-
ment is the Time-Correlated Single Photon Counting
(TCSPC) technique in which very short light pulses
(typically picosecond to nanosecond) are used to
excite the molecules of the analyte. The distribution
in delay times between the excitation pulse and the
detection of single fluorescence photons is recorded
and a decay curve of the dye is created, illustrating
the fluorescence intensity as a function of time [20].
The addition of components which polarize the light
(polarizers) on this instrumentation adds the capabil-
ity of monitoring the rotation of the fluorophore.
The literature shows an extended interest in ani-
sotropic properties of lipid bilayers over several dec-
ades, and these approaches have revealed the
behaviour of the membranes under different condi-
tions, usually altering the temperature, pH and lipid
composition, using liposomes as artificial membrane
models [140]. The results prove that depolarization
measurements are sensitive to minor changes in the
system under different physical and chemical condi-
tions [141–143].
There has been extensive use of this technique in
studying lipid rafts of cell membranes even from
the 70s [144,145] to the past decade [146,147]. In
the field of EVs, researchers have used the technique
to examine the behaviour of the vesicle membrane
under different physicochemical conditions extract-
ing information about their rigidity. EVs from mast
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cells and dendritic cells have shown a difference in
fluidity with the rise of pH from 5 to 7, suggesting
that membrane re-organization takes place from the
acidic environment of the multivesicular bodies to
the neutral extracellular matrix. In practice, the vesi-
cles were stained with DPH (diphenyl-hexatriene)
and their anisotropy was measured in a steady-state
system for different pH and temperature points
[148]. A similar system using DPH and steady-state
depolarization measurement has been used to inves-
tigate the membrane microviscosity on epididymo-
somes, the EVs secreted in the epididymal fluid. The
results showed that the proportion of sphingomyelin
in the epididymal membrane increases significantly
in transit from the first compartments of the epidi-
dymis (caput) towards the “tail” (cauda) of the
epithelium, and this change in lipid composition is
evident by the increase of the membrane rigidity
[149], giving implications for use on EVs from
other tissues. Another example of steady-state aniso-
tropy measurement for DPH-stained vesicles from
ovarian cancer comes from Shenoy et al., who stu-
died the membrane order and phase transition of the
particles for a range of temperatures and conclude
the lamellarity of the vesicles, evident by the broad
phase transition points around 37°C [150]. However,
there is a lack of publications on EV depolarization
measurements using time-resolved anisotropy instru-
mentation (TCSPC) to date. Time-resolved fluores-
cence anisotropy can also be applied to FLIM [151].
In this review, we have focused on the phenotypic
analysis of EVs highlighting the versatility of fluores-
cence. It is also important to acknowledge techniques
which use principles different from fluorescence, but
which are of great significance in EV analysis (e.g.
Raman spectroscopy, mass spectroscopy for lipids and
proteins analyses, nucleic acid sequencing, small-angle
X-ray scattering (SAXS), micronuclear magnetic reso-
nance (microNMR), electron microscopy (EM),
cryoEM-tomography and numerous others).
Future outlooks in EV analysis
There are currently many outstanding questions about the
biology of EVs including their routes of biogenesis, release
and uptake mechanisms by recipient tissues in vivo, as well
as their lifetime in the blood circulation. More advanced
tools are required to address these properties of EVs and
one of the future directions could be the combination of
fluorescence with other optical techniques, as well asmulti-
plexed analysis by adding modalities which use different
and non-overlapping principles.
For example, in NTA, advances in the method
would tackle limitations such as the speed of sample
analysis and allow fluorescence screening for multiple
surface markers. Currently, instruments with two dif-
ferent fluorescence channels are under development, so
that samples labelled with two fluorescent probes can
be studied simultaneously, and in addition to this, it is
being converted to high-throughput versions, such as
with the use of an autosampler [68]. Another recently
commercialized platform for EV phenotyping has been
developed by Nanoview Biosciences, Boston, and uses
single particle interferometric reflectance imaging sen-
sing (SP-IRIS). In more detail, the EVs are captured on
an array coated with CD9, CD63 and CD81 and they
can then be stained and imaged at the level of single
particles. EVs larger than 50 nm can be probed for up
to three fluorescent markers simultaneously, while the
analysis ensures only EV are measured, in contrast to
NTA approaches which count all particles above the
detection limit of diameter [152]. An approach similar
to this is the single EV analysis (SEA), which is based
on the immobilization of EV on a microfluidics com-
partment followed by staining and imaging of single
vesicles. The EV were pre-biotinylated and were cap-
tured on a neutravidin surface, on which staining and
washing solutions of antibodies could be introduced.
The final microscopy imaging was followed by proces-
sing of the signal and identification of the fluorescent
markers on the single EVs [153].
Also, a recent and promising development for FLIM is
the introduction of single-photon avalanche diode
(SPAD) array cameras with on-chip pixelated timing
capabilities [117,154]. This provides a convenient imple-
mentation of multiplexed fluorescence decay measure-
ments [155] as it replaces the need to scan a sample,
resulting in fast FLIMmeasurements in sub-second time-
scales. This capability presents exciting opportunities for
fluorescence lifetime-based live cell imaging and with
bespoke nanoprobes for the detection of transient bio-
markers such as mRNA [156] in fluid biopsy/flow
cytometry.
Looking into the current approaches for EV phenotyp-
ing, we conclude that the heterogeneity of size and com-
position of EVs dictates the use of multiple techniques in
order to eliminate the errors resulting from the differences
in size. Moreover, the chemistry of fluorescent probes has
seen rapid development. There is currently a wide range of
options and the selection of the appropriate probe depends
on the imaging strategy, as some methods have specific
requirements (e.g. STORM, FRET). Because of the grow-
ing interest in the use of EVs in clinical analysis, standar-
dization of the phenotyping guidelines is required, as there
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is significant variability in the techniques in current use. As
one of the key questions about extracellular vesicles still
remaining is the mechanism of interaction with tissues
in vivo, future research could be directed towards the
development of live EV imaging and tracking in living
models (similar to Verweij et al., as mentioned earlier).
Finally, the need for clinically applicable devices has started
with the development of microfluidics and arrays, which
promise rapid, point-of-care analysis of multiple markers
simultaneously. Fluorescence-based methodologies for
phenotyping EVs in healthcare applications will undoubt-
edly continue to develop apace and future EV-based diag-
nostics are highly likely to increase in efficacy and
popularity.
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